Do not modify, reduce, or discontinue usual therapies without a specific clinical indication in children and adolescents with chronic disease and COVID-19.
Children with chronic illnesses are a high-risk population from an infectious standpoint and, therefore, may be susceptible to developing more severe SARS-CoV-2 illness. Of relevance is the recommendation to educate children and their families about preventive...
Do not administer drug therapy other than symptomatic drugs in pediatric and adolescent cases of COVID-19 for which hospitalization is not required.
Symptomatic treatment is the same as that used for common respiratory infections and gastroenteritis. In the majority of symptomatic cases of pediatric and adolescent SARS-CoV-2 infection, symptomatic therapy alone with acetaminophen or ibuprofen in the absence of...
Don’t prescribe antibiotic therapy to patients colonized by multi-resistant antibiotics microorganisms without signs of infection.
This indication takes origin from the difference between colonization and infection: the former consists in the simple demonstration of the presence of a germ; the latter in the demonstration of local and/or systemic signs of germ-dependent inflammation. Both patients...
Don’t use fluoroquinolone antibiotics in empiric therapies, even if for severe infections, but use antibiotics with less impact on antibiotic resistance phenomenon and with less side effects.
After the amino penicillin, fluoroquinolones, and in particular levofloxacin and ciprofloxacin, are the antibiotics utilized the most in Italy. The resistance of most microorganisms to fluoroquinolones, that is constantly increasing and it is proportional to the use...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments